Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21919823

Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Leuk Lymphoma
Publication date
2012 Mar
First author
Gritti G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gritti G
      type
      Author
    2. name
      Reda G
      type
      Author
    3. name
      Maura F
      type
      Author
    4. name
      Piciocchi A
      type
      Author
    5. name
      Baldini L
      type
      Author
    6. name
      Molica S
      type
      Author
    7. name
      Neri A
      type
      Author
    8. name
      Cortelezzi A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gritti G
      type
      Author
    2. name
      Reda G
      type
      Author
    3. name
      Maura F
      type
      Author
    4. name
      Piciocchi A
      type
      Author
    5. name
      Baldini L
      type
      Author
    6. name
      Molica S
      type
      Author
    7. name
      Neri A
      type
      Author
    8. name
      Cortelezzi A
      type
      Author
    bibliography ids
    1. nci-bib-ab7b03eafd6c506813cd7748
    book metadata
    content sha256
    dd7325ed31d09042b24c40e8335f7404c59b37a8688f5ab41e2367f6a261fd17
    document type
    citation
    dois
    1. 10.3109/10428194.2011.623258
    electronic publication date
    display
    2012 Jan 5
    precision
    day
    year
    2012
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:21919823
    immutable id
    pubmed:21919823@dd7325ed31d09042b24c40e8335f7404c59b37a8688f5ab41e2367f6a261fd17
    journal
    abbreviation
    Leuk Lymphoma
    issn electronic
    1029-2403
    issn print
    1026-8022
    issue
    3
    name
    Leukemia & lymphoma
    nlm unique id
    9007422
    pages
    424-9
    volume
    53
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      21919823
      provenance
      batch id
      2529ef2eca926738ab13
      provider
      NCBI PubMed ESummary
      record sha256
      079b9ecfd90f89c459f058241d86ad55631e49f84e5562d4c911bde7b00b3581
      response sha256
      9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
      retrieved at
      2026-09-09T23:46:42.856296+00:00
      publication date
      display
      2012 Mar
      precision
      month
      year
      2012
      publication types
      1. Comparative Study
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/21919823/
      title
      Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia.

      Preserved source evidence · Not medical advice